Breaking News Instant updates and real-time market news.

MDT

Medtronic

$77.99

0.29 (0.37%)

08:01
02/17/17
02/17
08:01
02/17/17
08:01

Medtronic announces Japanese regulatory approval for Micra system

Medtronic announced Japan regulatory approval for the Micra Transcatheter Pacing System. Japan's Pharmaceuticals and Medical Device Agency granted approval for Micra based on positive data from the Medtronic Micra TPS Global Clinical Trial, which enrolled 744 patients and evaluated the safety and efficacy of the device through a single-arm, multi-center study at 56 centers in 19 countries, including Japan.

  • 17

    Feb

  • 21

    Feb

  • 27

    Feb

  • 27

    Feb

  • 07

    Mar

  • 17

    Mar

  • 21

    Mar

MDT Medtronic
$77.99

0.29 (0.37%)

01/10/17
PIPR
01/10/17
NO CHANGE
Target $25
PIPR
Overweight
K2M remains 'under-owned and misunderstood,' says Piper Jaffray
Piper Jaffray analyst Matt O'Brien says K2M Group (KTWO) finished the year solidly after the company preannounced better than expected Q4 results. While the stock should be up today, the company remains "'under-owned and misunderstood," O'Brien tells investors in a research note. K2M over the last few years has quietly taken market share from Johnson & Johnson (JNJ) and Medtronic (MDT) in the $1.4B deformity market, the analyst writes. O'Brien keeps an Overweight rating on the shares with a $25 price target.
01/13/17
SPHN
01/13/17
NO CHANGE
Target $75
SPHN
Overweight
Stephens remains bullish on Dexcom after CMS news
Stephens analyst Chris Cooley reiterates an Overweight rating and $75 price target on Dexcom's (DXCM) shares after the Centers for Medicare and Medicaid Services, or CMS, created a separate benefit category for "therapeutic continuous glucose monitoring, or CGM," establishing Medicare reimbursement for the company's G5 Mobile CGM System 1 year earlier than previously assumed by the Street. The news, coupled with the recent announcement by Medtronic (MDT) to delay the full commercial domestic launch of the 670G, serves to further bolster his confidence in the company's 2017 revenue growth outlook.
02/14/17
WELS
02/14/17
NO CHANGE
WELS
Medtronic data likely to be positive, says Wells Fargo
Wells Fargo predicts that data on Medtronic's (MDT) CoreValve/Evolut R, due to be presented on March 17, will show that the device "is superior to surgical aortic valve replacement in intermediate risk patients." If the results come in as expected, the device should be approved in the U.S. by early fall, according to the firm. Wells Fargo adds that the data should also be a positive for other TAVR stocks, including Edwards Lifesciences (EW) and Boston Scientific (BSX). Wells keeps Outperform ratings on all three stocks.
02/15/17
DBAB
02/15/17
NO CHANGE
Target $96
DBAB
Buy
Medtronic shares have more upside, says Deutsche Bank
Deutsche Bank analyst Kristen Stewart says the recent stock appreciation has not changed her bullish view on Medtronic. Ahead of the company's Q3 results on February 21, Stewart sees more upside in the stock. She keeps a Buy rating on Medtronic with a $96 price target.

TODAY'S FREE FLY STORIES

AMZN

Amazon.com

$1,168.92

6.92 (0.60%)

05:24
12/12/17
12/12
05:24
12/12/17
05:24
Hot Stocks
AWS, NWCD announce second AWS region in China now available to customers »

Amazon Web Services, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

SAIL

SailPoint Technologies

$14.83

-0.61 (-3.95%)

05:23
12/12/17
12/12
05:23
12/12/17
05:23
Initiation
SailPoint Technologies initiated  »

SailPoint Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GTY

Getty Realty

$28.10

0.08 (0.29%)

05:22
12/12/17
12/12
05:22
12/12/17
05:22
Initiation
Getty Realty initiated  »

Getty Realty initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNK

Mallinckrodt

$23.14

0.84 (3.77%)

05:16
12/12/17
12/12
05:16
12/12/17
05:16
Recommendations
Mallinckrodt analyst commentary  »

Mallinckrodt management…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SFIX

Stitch Fix

$23.98

0.38 (1.61%)

05:13
12/12/17
12/12
05:13
12/12/17
05:13
Initiation
Stitch Fix initiated  »

Stitch Fix initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

WEB

Web.com

$23.00

1.2 (5.50%)

05:10
12/12/17
12/12
05:10
12/12/17
05:10
Downgrade
Web.com rating change  »

Web.com downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNPS

Synopsys

$89.56

-0.95 (-1.05%)

05:09
12/12/17
12/12
05:09
12/12/17
05:09
Downgrade
Synopsys rating change  »

Synopsys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSNC

SS&C

$41.38

0.75 (1.85%)

05:09
12/12/17
12/12
05:09
12/12/17
05:09
Downgrade
SS&C rating change  »

SS&C downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NOW

ServiceNow

$123.09

1.28 (1.05%)

05:08
12/12/17
12/12
05:08
12/12/17
05:08
Downgrade
ServiceNow rating change  »

ServiceNow downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

RNG

RingCentral

$47.55

-0.75 (-1.55%)

05:08
12/12/17
12/12
05:08
12/12/17
05:08
Downgrade
RingCentral rating change  »

RingCentral downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QTWO

Q2 Holdings

$40.35

-0.1 (-0.25%)

05:07
12/12/17
12/12
05:07
12/12/17
05:07
Downgrade
Q2 Holdings rating change  »

Q2 Holdings downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

QLYS

Qualys

$59.00

0.55 (0.94%)

05:07
12/12/17
12/12
05:07
12/12/17
05:07
Downgrade
Qualys rating change  »

Qualys downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$61.44

-0.26 (-0.42%)

05:06
12/12/17
12/12
05:06
12/12/17
05:06
Downgrade
PTC rating change  »

PTC downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEWR

New Relic

$60.00

2.77 (4.84%)

05:06
12/12/17
12/12
05:06
12/12/17
05:06
Downgrade
New Relic rating change  »

New Relic downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

TYPE

Monotype Imaging

$24.40

-0.2 (-0.81%)

05:05
12/12/17
12/12
05:05
12/12/17
05:05
Downgrade
Monotype Imaging rating change  »

Monotype Imaging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MODN

Model N

$16.00

0.05 (0.31%)

05:05
12/12/17
12/12
05:05
12/12/17
05:05
Downgrade
Model N rating change  »

Model N downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MIME

Mimecast

$28.02

-0.72 (-2.51%)

05:04
12/12/17
12/12
05:04
12/12/17
05:04
Downgrade
Mimecast rating change  »

Mimecast downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMPV

Imperva

$41.85

0.3 (0.72%)

05:04
12/12/17
12/12
05:04
12/12/17
05:04
Downgrade
Imperva rating change  »

Imperva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDDY

GoDaddy

$48.95

0.07 (0.14%)

05:03
12/12/17
12/12
05:03
12/12/17
05:03
Downgrade
GoDaddy rating change  »

GoDaddy downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FTNT

Fortinet

$42.22

0.27 (0.64%)

05:02
12/12/17
12/12
05:02
12/12/17
05:02
Downgrade
Fortinet rating change  »

Fortinet downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

  • 17

    Jan

CSGP

CoStar Group

$290.50

-1.84 (-0.63%)

05:02
12/12/17
12/12
05:02
12/12/17
05:02
Downgrade
CoStar Group rating change  »

CoStar Group downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

  • 15

    Dec

  • 26

    Feb

CHKP

Check Point

$105.85

1.07 (1.02%)

05:01
12/12/17
12/12
05:01
12/12/17
05:01
Downgrade
Check Point rating change  »

Check Point downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

CUDA

Barracuda

$27.61

0.08 (0.29%)

05:00
12/12/17
12/12
05:00
12/12/17
05:00
Downgrade
Barracuda rating change  »

Barracuda downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$174.31

0.74 (0.43%)

04:59
12/12/17
12/12
04:59
12/12/17
04:59
Downgrade
Adobe rating change  »

Adobe downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

SAIL

SailPoint Technologies

$14.83

-0.61 (-3.95%)

04:56
12/12/17
12/12
04:56
12/12/17
04:56
Initiation
SailPoint Technologies initiated  »

SailPoint Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.